Vaccine Scheduler

Liechtenstein: Recommended vaccinations

	General recommendation
	Recommendation for specific groups only
	Catch-up (e.g. if previous doses missed)
	Vaccination not funded by the National Health system
	Mandatory vaccination

	Birth	Months					Years
	Birth	2	4	6	9	12	2	4-7	8-10	11	12	15	16	18	25	26	40	45	64	≥ 65
Coronavirus disease (COVID-19)											COVID-19²									COVID-19³

tuberculosis	BCG⁴

diphtheria		D	D			D		D⁵	d	d					d⁶			d⁶		d⁶
tetanus		TT	TT			TT		TT⁵	TT	TT					TT⁶			TT⁶		TT⁶
pertussis		acP	acP			acP		acP⁵	acp	acp					acp⁶
poliomyelitis		IPV	IPV			IPV		IPV⁷
Haemophilus influenzae type b infection		Hib	Hib			Hib
hepatitis B	HepB⁸	HepB	HepB			HepB				HepB⁹

pneumococcal disease		PCV13 or PCV15	PCV13 or PCV15			PCV13 or PCV15								PCV15 or PCV20						PCV15 or PCV20

meningococcal disease							MCV4¹⁰			MCV4¹¹

measles					MEAS¹²	MEAS¹²		MEAS¹³
mumps					MUMPS¹²	MUMPS¹²		MUMPS¹³
rubella					RUBE¹²	RUBE¹²		RUBE¹³

varicella¹					VAR	VAR							VAR¹⁴

human papillomavirus infection										HPV9 (F/M)¹⁵			HPV9 (F/M)¹⁶

influenza				IIV4¹⁷											IIV4¹⁸

herpes zoster																				ZOS

Version:

Footnotes:

Recommended for all <40 years if they have not had the disease, especially young women planning to have children. In addition for persons with increased risk of complications due to immune deficiency.
Vaccination is strongly recommended to prevent severe courses of the disease for people over 65 years of age and particularly vulnerable people with chronic illnesses as well as pregnant women.n More information: https://www.llv.li/de/privatpersonen/gesundheit-vorsorge-und-pflege/krankheiten-und-risiken/coronavirus/covid-19-impfungen
Vaccination is strongly recommended to prevent severe courses of the disease for people over 65 years of age and particularly vulnerable people with chronic illnesses as well as pregnant women. More information: https://www.llv.li/de/privatpersonen/gesundheit-vorsorge-und-pflege/krankheiten-und-risiken/coronavirus/covid-19-impfungen
for newborns and infants under 12 months, if their parents are from countries with high TB prevalence
A lower dose of diphtheria toxoid (d) and whooping cough (ap) can also be used (dTap) The pertussis booster provided between the ages of 4 and 7 years should be administered no later than school entry.
Booster at 25 years (dTap), 45 years (dT) and 65 years (dT), and then every 10 years (dT)
Additional polio boosters are needed for people at increased risk. This concerns travelers to countries infected with poliovirus or with risk of exposure to poliovirus and people working with poliovirus. Boosters are usually given 10 years after the previous dose.
Babies born of HBsAg positive mothers: 1st dose of monovalent vaccine and HB immunoglobulins administered at birth. Monovalent vaccine to be used also for the 2nd dose at 1 month of age, hexavalent combination vaccine can be used for the 3rd and 4th doses at 2 and 12 months of age
For individuals who have not been vaccinated previously. Can be given at the same time as vaccination against HPV.
Not part of the routine vaccination programme but can be offered by health professionals. Catch-up possible until 5 years of age.
Not part of the routine vaccination programme but can be offered by health professionals. Catch-up possible until 20 years of age.
Depending on the risk evaluation of the risk of measles, administration of the second dose of MMR is possible between 12 and 15 months of age. In case of an outbreak, or contact with a measles case, or travel to endemic area, vaccination is recommended starting at six months of age. If the first dose of MMR is given between six and eight months of age, three doses of MMR are necessary to complete the immunisation cycle.
Catch up on vaccination (1 or 2 doses at least one month apart, depending on the number of doses received previously): in particular children, adolescents and adults born after 1963; women of childbearing age or women who have recently given birth. Do not administer this vaccination in case of known pregnancy or immunosuppression
Catch-up (2 doses at least 4 weeks apart) in young adults (<40 years of age) with no history of past infection.
Gender-neutral (boys and girls) 9-valent vaccination offered. Two-dose schedule.
Gender neutral vaccination catch up. 3 doses with 9-valent.
For 6 months to 8 years, vaccination is not recommended for healthy children but is recommended for premature babies (born before gestational week 33 (e.g. <32 weeks and seven days of pregnancy) or with a birth weight of less than 1 500g) from the age of six months and for the first two winters after birth. For 6 months to 18 years, vaccination is recommended for children and adolescents with chronic medical conditions.
For individuals aged >=18 years, the recommended influenza vaccines are Vaxigrip Tetra®, Fluarix Tetra®, Influvac Tetra®, and Flucelvax Tetra®. The same vaccines (Vaxigrip Tetra®, Fluarix Tetra®, Influvac Tetra®, Flucelvax Tetra®) are also recommended for those aged >=50, >=55, >=59, and >=60 years. For individuals aged >=65 years, the recommended vaccine is Efluelda®.

More information available at:
https://www.bag.admin.ch/bag/fr/home/gesund-leben/gesundheitsfoerderung-und-praevention/impfungen-prophylaxe/schweizerischer-impfplan.html

Date of last update: 14 April 2023